These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 24422969

  • 21. Surface modification of hollow gold nanoparticles conducted by incorporating cancer cell membrane and AS1411 aptamer, aiming to achieve a dual-targeted therapy for colorectal cancer.
    Hassibian S, Taghdisi SM, Jamshidi Z, Samie A, Alinezhad Nameghi M, Shayan M, Farrokhi N, Alibolandi M, Ramezani M, Dehnavi SM, Abnous K.
    Int J Pharm; 2024 Apr 25; 655():124036. PubMed ID: 38522491
    [Abstract] [Full Text] [Related]

  • 22. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism.
    Reyes-Reyes EM, Teng Y, Bates PJ.
    Cancer Res; 2010 Nov 01; 70(21):8617-29. PubMed ID: 20861190
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Aptamer-Functionalized Gold Nanostars for on-Demand Delivery of Anticancer Therapeutics.
    Wu D, Zhao P, Wu L, Lin L, Yu G, Xu L, Yue J.
    ACS Appl Bio Mater; 2020 Jul 20; 3(7):4590-4599. PubMed ID: 35025458
    [Abstract] [Full Text] [Related]

  • 25. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M, Taghdisi SM, Ramezani P, Hosseini Shamili F, Farzad SA, Abnous K, Ramezani M.
    Int J Pharm; 2017 Mar 15; 519(1-2):352-364. PubMed ID: 28126548
    [Abstract] [Full Text] [Related]

  • 26. Exploiting the Catalytic Ability of Polydopamine-Remodeling Gold Nanoparticles toward the Naked-Eye Detection of Cancer Cells at a Single-Cell Level.
    Yang BZ, Su ZY, Jou AF.
    ACS Appl Bio Mater; 2021 Mar 15; 4(3):2821-2828. PubMed ID: 35014321
    [Abstract] [Full Text] [Related]

  • 27. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    Cheng Y, Zhao G, Zhang S, Nigim F, Zhou G, Yu Z, Song Y, Chen Y, Li Y.
    PLoS One; 2016 Mar 15; 11(12):e0167094. PubMed ID: 27907160
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
    Lee KY, Kang H, Ryu SH, Lee DS, Lee JH, Kim S.
    J Biomed Biotechnol; 2010 Mar 15; 2010():168306. PubMed ID: 20204158
    [Abstract] [Full Text] [Related]

  • 30. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
    Wang H, Zhu Z, Zhang G, Lin F, Liu Y, Zhang Y, Feng J, Chen W, Meng Q, Chen L.
    J Pharm Sci; 2019 Nov 15; 108(11):3684-3694. PubMed ID: 31465736
    [Abstract] [Full Text] [Related]

  • 31. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
    Mehrnia SS, Hashemi B, Mowla SJ, Nikkhah M, Arbabi A.
    Radiat Oncol; 2021 Feb 10; 16(1):33. PubMed ID: 33568174
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
    Fang K, Wang L, Huang H, Dong S, Guo Y.
    Nanotechnology; 2021 Mar 25; 32(24):. PubMed ID: 33690196
    [Abstract] [Full Text] [Related]

  • 33. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K, Danesh NM, Ramezani M, Charbgoo F, Bahreyni A, Taghdisi SM.
    Expert Opin Drug Deliv; 2018 Nov 25; 15(11):1045-1052. PubMed ID: 30269603
    [Abstract] [Full Text] [Related]

  • 34. Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells.
    Zhou Y, Yang Q, Wang F, Zhou Z, Xu J, Cheng S, Cheng Y.
    Int J Nanomedicine; 2021 Nov 25; 16():1805-1817. PubMed ID: 33692623
    [Abstract] [Full Text] [Related]

  • 35. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
    Lohlamoh W, Soontornworajit B, Rotkrua P.
    Asian Pac J Cancer Prev; 2021 Jul 01; 22(7):2209-219. PubMed ID: 34319045
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M, Ramezani M, Abnous K, Hadizadeh F.
    J Pharm Sci; 2016 May 01; 105(5):1741-1750. PubMed ID: 27039356
    [Abstract] [Full Text] [Related]

  • 38. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.
    Liang X, Wang Y, Shi H, Dong M, Han H, Li Q.
    Int J Nanomedicine; 2021 May 01; 16():2569-2584. PubMed ID: 33833512
    [Abstract] [Full Text] [Related]

  • 39. Delivery of 5-fluorouracil for cancer therapy using aptamer-based nonlinear hybridization chain reaction.
    Ji H, He Z, Huang Y, Cao X, Zhu Q.
    Int J Pharm; 2024 Sep 05; 662():124539. PubMed ID: 39074647
    [Abstract] [Full Text] [Related]

  • 40. Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells.
    Taghavi S, Nia AH, Abnous K, Ramezani M.
    Int J Pharm; 2017 Jan 10; 516(1-2):301-312. PubMed ID: 27840158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.